Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks? Export

@article{citeulike:5881688, author = {Nurmohamed, Michael T.}, citeulike-article-id = {5881688}, citeulike-linkout-0 = {http://www.ingentaconnect.com/content/adis/dgs/2009/00000069/00000015/art00002}, issn = {0012-6667}, journal = {Drugs}, number = {15}, pages = {2035--2043}, posted-at = {2009-10-03 17:31:55}, publisher = {Adis International}, title = {Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks?}, url = {http://www.ingentaconnect.com/content/adis/dgs/2009/00000069/00000015/art00002}, volume = {69} }

TY - JOUR ID - citeulike:5881688 L3 - citeulike-article-id:5881688 IS - 15 JF - Drugs SN - 0012-6667 EP - 2043 TI - Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks? PB - Adis International VL - 69 SP - 2035 AU - Nurmohamed, Michael UR - http://www.ingentaconnect.com/content/adis/dgs/2009/00000069/00000015/art00002 ER -